Cediranib for Metastatic Alveolar Soft Part Sarcoma

PURPOSE: Alveolar soft part sarcoma (ASPS) is a rare, highly vascular tumor, for which no effective standard systemic treatment exists for patients with unresectable disease. Cediranib is a potent, oral small-molecule inhibitor of all three vascular endothelial growth factor receptors (VEGFRs). PATI...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kummar, Shivaani, Allen, Deborah, Monks, Anne, Polley, Eric C., Hose, Curtis D., Ivy, S. Percy, Turkbey, Ismail B., Lawrence, Scott, Kinders, Robert J., Choyke, Peter, Simon, Richard, Steinberg, Seth M., Doroshow, James H., Helman, Lee
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2013
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3677840/
https://ncbi.nlm.nih.gov/pubmed/23630200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.47.4288
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller